• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血后处理对急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后心肾损伤的预防作用

[Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].

作者信息

Wang Y Y, Li T, Liu Y W, Liu B J, Hu X M, Wang Y, Gao W Q, Wu P, Huang L, Li X, Peng W J, Ning M

机构信息

Key Laboratory for Artificial Cells of Tianjin, Artificial Cell Engineering Technology Research Center of Ministry of Health, Department of Cardiac Center, Third Central Hospital of Tianjin, Tianjin 300170, China.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Apr 24;45(4):277-282. doi: 10.3760/cma.j.issn.0253-3758.2017.04.005.

DOI:10.3760/cma.j.issn.0253-3758.2017.04.005
PMID:28545277
Abstract

To evaluate the effect of the ischemic post-conditioning (IPC) on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction (STEMI) after primary percutaneous coronary intervention (PPCI). A total of 251 consecutive STEMI patients underwent PPCI in the heart center of Tianjin Third Central Hospital from January 2012 to June 2014 were enrolled in this prospective, randomized, control, single-blinded, clinical registry study. Patients were randomly divided into IPC group (123 cases) and control group (128 cases) with random number table. Patients in IPC group underwent three times of inflation/deflation with low inflation pressure using a balloon catheter within one minute after culprit vessel blood recovery, and then treated by PPCI. Patients in control group received PPCI procedure directly. The basic clinical characteristics, incidence of reperfusion arrhythmia during the procedure, the rate of electrocardiogram ST-segment decline, peak value of myocardial necrosis markers, incidence of contrast induced acute kidney injury(CI-AKI), and one-year major adverse cardiovascular events(MACE) which including myocardial infarction again, malignant arrhythmia, rehospitalization for heart failure, repeat revascularization, stroke, and death after the procedure were analyzed between the two groups. The age of IPC group and control group were comparable((61.2±12.6) vs. (64.2±12.1) years old, =0.768). The incidence of reperfusion arrhythmia during the procedure was significantly lower in the IPC group than in the control group(42.28% (52/123) vs. 57.03% (73/128), =0.023). The rate of electrocardiogram ST-segment decline immediately after the procedure was significantly higher in the IPC group than in the control group (77.24% (95/123) vs. 64.84% (83/128), =0.037). The peak value of myocardial necrosis markers after the procedure were significantly lower in the IPC group than in the control group(creatine kinase: 1 257 (682, 2 202) U/L vs. 1 737(794, 2 816)U/L, =0.029; creatine kinase-MB: 123(75, 218)U/L vs.165(95, 288)U/L, =0.010). The rate of CI-AKI after the procedure was significantly lower in the IPC group than in the control group(5.69%(7/123) vs. 14.06%(18/128), =0.034). The rate of the one-year MACE was significantly lower in the IPC group than in the control group(7.32%(9/123) vs. 15.63% (20/128), =0.040). The IPC strategy performed eight before PPCI can reduce myocardial ischemia- reperfusion injury, decline the rates of CI-AKI and one-year MACE significantly in STEMI patients, thus has a significant protective effect on heart and kidney in STEMI patients. Clinical Trial Registration Chinese Clinical Trials Registry, ChiCTR-ICR-15006590.

摘要

评估缺血后适应(IPC)对急性ST段抬高型心肌梗死(STEMI)患者在直接经皮冠状动脉介入治疗(PPCI)后预防心肾损伤的效果。选取2012年1月至2014年6月在天津市第三中心医院心脏中心连续接受PPCI的251例STEMI患者,纳入这项前瞻性、随机、对照、单盲临床注册研究。采用随机数字表法将患者随机分为IPC组(123例)和对照组(128例)。IPC组患者在罪犯血管血流恢复后1分钟内使用球囊导管以低充气压力进行3次充气/放气,然后接受PPCI治疗。对照组患者直接接受PPCI手术。分析两组患者的基本临床特征、术中再灌注心律失常发生率、心电图ST段下降率、心肌坏死标志物峰值、对比剂诱导的急性肾损伤(CI-AKI)发生率以及术后1年主要不良心血管事件(MACE),包括再次心肌梗死、恶性心律失常、因心力衰竭再次住院、重复血运重建、卒中及死亡情况。IPC组和对照组患者年龄相当((61.2±12.6)岁 vs.(64.2±12.1)岁,P =0.768)。IPC组术中再灌注心律失常发生率显著低于对照组(42.28%(52/123) vs. 57.03%(73/128),P =0.023)。术后即刻IPC组心电图ST段下降率显著高于对照组(77.24%(95/123) vs. 64.84%(83/128),P =0.037)。术后IPC组心肌坏死标志物峰值显著低于对照组(肌酸激酶:1257(682,2202)U/L vs. 1737(794,2816)U/L,P =0.029;肌酸激酶同工酶:123(75,218)U/L vs. 165(95,288)U/L,P =0.010)。术后IPC组CI-AKI发生率显著低于对照组(5.69%(7/123) vs. 14.06%(18/。128),P =0.034)。IPC组术后1年MACE发生率显著低于对照组(7.32%(9/123) vs. 15.63%(20/128),P =0.040)。PPCI前实施8次的IPC策略可减轻STEMI患者心肌缺血-再灌注损伤,显著降低CI-AKI发生率及术后1年MACE发生率,从而对STEMI患者的心肾具有显著保护作用。临床试验注册号:中国临床试验注册中心,ChiCTR-ICR-15006590。

相似文献

1
[Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].缺血后处理对急性ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后心肾损伤的预防作用
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Apr 24;45(4):277-282. doi: 10.3760/cma.j.issn.0253-3758.2017.04.005.
2
Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.下肢缺血后处理在经皮冠状动脉介入治疗中的应用可安全减少前壁心肌梗死的酶性梗死面积:一项随机对照试验。
JACC Cardiovasc Interv. 2013 Oct;6(10):1055-63. doi: 10.1016/j.jcin.2013.05.011.
3
[The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].[ST段抬高型心肌梗死患者经皮冠状动脉介入治疗前冠状动脉内注射尼可地尔对心肌灌注及临床结局的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Jan 25;45(1):26-33. doi: 10.3760/cma.j.issn.0253-3758.2017.01.006.
4
Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI).上臂远程缺血后处理(RIPC)可减少急性 ST 段抬高型心肌梗死(STEMI)患者行直接经皮冠状动脉介入治疗(PCI)后的心肌缺血再灌注损伤。
Med Sci Monit. 2018 Feb 19;24:1017-1026. doi: 10.12659/msm.908247.
5
Effects of ischaemic postconditioning on outcomes of patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention: a meta-analysis.缺血后处理对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者结局的影响:一项荟萃分析。
BMJ Open. 2019 Mar 23;9(3):e022509. doi: 10.1136/bmjopen-2018-022509.
6
Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A single-center cross-sectional study.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗期间缺血后适应的效果:一项单中心横断面研究。
Ann Card Anaesth. 2019 Oct-Dec;22(4):347-352. doi: 10.4103/aca.ACA_126_18.
7
[Protective effect of ischemia postconditioning on reperfusion injury in patients with ST-segment elevation acute myocardial infarction].缺血后适应对ST段抬高型急性心肌梗死患者再灌注损伤的保护作用
Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jan;39(1):35-9.
8
Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗期间缺血后适应的替代指标和临床结局:15项随机试验的荟萃分析
Catheter Cardiovasc Interv. 2014 Nov 15;84(6):978-86. doi: 10.1002/ccd.25581. Epub 2014 Jul 14.
9
Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.直接经皮冠状动脉介入治疗中的缺血后处理:对 ST 段抬高型心肌梗死患者心肌再灌注影响的后处理(POST)随机试验。
Circulation. 2013 Oct 22;128(17):1889-96. doi: 10.1161/CIRCULATIONAHA.113.001690. Epub 2013 Sep 25.
10
Effect of comprehensive remote ischemic conditioning in anterior ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Design and rationale of the CORIC-MI randomized trial.综合远程缺血预处理在接受直接经皮冠状动脉介入治疗的前壁ST段抬高型心肌梗死中的作用:CORIC-MI随机试验的设计与原理
Clin Cardiol. 2018 Aug;41(8):997-1003. doi: 10.1002/clc.22973. Epub 2018 Aug 16.

引用本文的文献

1
Neuregulin-1, a potential therapeutic target for cardiac repair.神经调节蛋白-1,一种心脏修复的潜在治疗靶点。
Front Pharmacol. 2022 Aug 31;13:945206. doi: 10.3389/fphar.2022.945206. eCollection 2022.